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O B J E C T I V E S We evaluated temporal trends and geographic variation in choice of stress testing
modality after percutaneous coronary intervention (PCI), as well as associations between modality and
procedure use after testing.
B A C KG ROUND Stress testing is frequently performed post-PCI, but the choices among available
modalities (electrocardiography only, nuclear, or echocardiography; pharmacological or exercise stress)
and consequences of such choices are not well characterized.
METHOD S CathPCI Registry® data were linked with identiﬁable Medicare claims to capture stress
testing use between 60 and 365 days post-PCI and procedures within 90 days after testing. Testing rates
and modality used were modeled on the basis of patient, procedure, and PCI facility factors, calendar
quarter, and Census Divisions using Poisson and logistic regression. Post-test procedure use was
assessed using Gray’s test.
R E S U L T S Among 284,971 patients, the overall stress testing rate after PCI was 53.1 per 100
person-years. Testing rates declined from 59.3 in quarter 1 (2006) to 47.1 in quarter 4 (2008), but the
relative use of modalities changed little. Among exercise testing recipients, adjusted proportions
receiving electrocardiography-only testing varied from 6.8% to 22.8% across Census Divisions; and
among exercise testing recipients having an imaging test, the proportion receiving echocardiography
(versus nuclear) varied from 9.4% to 34.1%. Post-test procedure use varied among modalities; exercise
electrocardiography-only testing was associated with more subsequent stress testing (13.7% vs. 2.9%;
p  0.001), but less catheterization (7.4% vs. 14.1%; p  0.001) than imaging-based tests.
CONC L U S I O N S Modest reductions in stress testing after PCI occurring between 2006 and 2008
cannot be ascribed to trends in use of any single modality. Additional research should assess whether
this trend represents better patient selection for testing or administrative policies (e.g., restricted access
for patients with legitimate testing needs). Geographic variation in utilization of stress modalities and
differences in downstream procedure use among modalities suggest a need to identify optimal use of
the different test modalities in individual patients. (J Am Coll Cardiol Img 2012;5:969–80) © 2012 by
the American College of Cardiology Foundation
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970ver the past 20 years, dramatic growth in
the utilization of cardiac stress testing has
led to multiple efforts to control utiliza-
tion (1–3). Commercial insurers have at-
tempted to reduce use through reimbursement cuts
and utilization management, including requiring
prior authorization or forcing test substitution (4,5).
Contemporaneously, professional societies led by
the American College of Cardiology Foundation
(ACCF) have responded to concerns about the
growth in utilization by defining appropriate use
criteria (AUC) for stress testing, including stress
echocardiography and nuclear imaging (6,7).
Perhaps due to these efforts, contempo-
rary evidence suggests that stress testing
rates have stabilized since 2005 (8); how-
ever, few data exist on trends in the
utilization of stress testing in specific pop-
ulations. One such population is patients
with recent percutaneous coronary inter-
vention (PCI)—a group that commonly
receives stress testing (9). Whether trends
also exist in the rates of use of different
stress testing modalities (e.g., nuclear ver-
sus echocardiography, and pharmacologi-
cal versus exercise stress) in this popula-
tion is similarly unclear. Finally, among
patients with a recent history of PCI,
predictors of different test modality use,
and the associations between testing mo-
dality and subsequent procedures, are un-
known. To address these issues, we used
detailed clinical data provided by the
CathPCI (Catheterization and Percutane-
ous Coronary Intervention) Registry® and
longitudinal data from the Centers for
Medicare and Medicaid Services (CMS)
to describe current patterns in stress test-
ing modalities after PCI.
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Data sources and CathPCI-Medicare data matching.
Percutaneous coronary intervention cases were
identified from the CathPCI Registry, a national
registry of patients undergoing cardiac catheteriza-
tion or PCI within the United States (10,11).
Included patients were those who received PCI
with stent insertion, were at least 65 years of age,
and were admitted and discharged between January
2005 and December 2008. Using the CathPCI
Registry records, the first PCI procedure with stent
insertion for each patient was considered to be their
index event and was treated as the unit of analysis.
Because the CathPCI Registry does not include
direct patient identifiers, events from the registry
were matched to Medicare inpatient claims using
indirect methods (12). We successfully linked
443,922 (66.0%) of all eligible index events to an
admission in the CMS database. For matched
records, the CMS data allowed identification of
subsequent resource use from inpatient, outpatient,
and physician claims, as well as enrollment and
mortality data from the Medicare denominator file.
The linked population has been shown to be rep-
resentative of the Medicare and CathPCI Registry
populations (13).
The linked CathPCI Registry-Medicare sample
was restricted to patients receiving 1 type of coro-
nary stent (bare metal or drug eluting) to facilitate
comparisons. Initial exclusion criteria were applied
to ensure complete resource use measurement. Pa-
tients were excluded if they did not have both Part
A and Part B Medicare coverage at the time of their
index admission, if physician claims for their index
event were missing, and if Medicare was serving as
a secondary payer. Next, we defined a 60-day
“blackout period” after each patient’s index event,
ed by the Agency for Healthcare Research and
ville, Maryland, as part of the Cardiovascular
er HHSA290-2005-0032-I-TO4-WA3 as part
. The authors of this manuscript are responsible
rsement by the U.S. Department of Health and
rt, Lung, and Blood Institute (F30-HL110483)
719). The contents of the manuscript are the
ational Heart, Lung, and Blood Institute or the
by the National Cardiovascular Data Registry
sent those of the authors, and do not necessarily
ies identified at www.ncdr.com. Dr. Shah reports
odest). Dr. Masoudi reports salary support from
cant). All other authors have reported they havensor
Rock
umb
gram
endo
Hea
008
the N
rted
epre
ciet
ht (m
gnifiB B R E V I A T I O N S
N D A C R O N YM S
ACCF American College o
Cardiology Foundation
AUC appropriate use crite
CABG coronary artery byp
grafting
CathPCI Catheterization a
Percutaneous Coronary
Intervention
CMS Centers for Medicare
Medicaid Services
CTA computed tomograp
angiography
ECG electrocardiogram
FS fee-for-service
HCPCS Healthcare Comm
Procedure Coding System
ICD-9-CM International
Classification of Diseases, Ni
Revision, Clinical Modificatio
NCDR National Cardiovas
Data Registry
OR odds ratio
PCI percutaneous coronar012, accepted July 19, 2012.
P
o
c
7
p
e
a
d
t
t
a
s
(
a
u
o
s
s
t
a
b
w
D
(
9
9
3
3
S
t
e
s
1
q
s
c
i
o
f
w
o
w
u
E
d
i
a
n
w
u
m
p
o
c
w
i
o
i
s
M
a
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 5 , N O . 1 0 , 2 0 1 2
O C T O B E R 2 0 1 2 : 9 6 9 – 8 0
Federspiel et al.
Stress Testing Patterns After PCI
971since diagnostic tests during this period may be
performed for cardiac rehabilitation, procedure
staging, or functional capacity assessments. Stress
testing use during this period was ignored, and
patients who ceased fee-for-service (FFS) Medicare
enrollment, died, underwent a repeat revasculariza-
tion or repeat catheterization, or were readmitted
for myocardial infarction (MI) during the blackout
period were excluded from analysis. Finally, pa-
tients who had a stress test, a competing event
(death, repeat catheterization, revascularization,
MI-related readmission), or were lost to follow-up
before January 1, 2006, were excluded; this restric-
tion was necessary to ensure that the incomplete
cohort of patients receiving testing available for
analysis during the 2005 calendar year did not
confound trend assessments.
Stress test population. Among the remaining
284,971 patients, we identified those who received
stress testing between 61 and 365 days after their
index event, not preceded by repeat revasculariza-
tion, catheterization, readmission for MI, or com-
puted tomography angiography (CTA). Only each
patient’s first eligible stress test was included in the
analysis. Because Healthcare Common Procedure
Coding System (HCPCS) codes are not provided
on inpatient claims, the use of pharmacological
stress could not be identified. Consequently, com-
parisons of test modality were limited to outpatient
stress testing as documented by place of service
codes on physician claims. Patients receiving stress
positron emission tomography or magnetic reso-
nance imaging were excluded because these tests
were rarely performed, precluding evaluation. We
also excluded patients who were coded as having
received both stress nuclear and stress echocardiog-
raphy procedures on the same day, as well as those
patients who were coded as having an electrocar-
diogram (ECG)-only stress test with use of phar-
macological stress, as these may represent coding
errors.
Data deﬁnitions. Use of cardiac stress testing after
CI was assessed by examining testing patterns
verall and by type of test, as identified by HCPCS
odes (ECG stress, 93015–93018; nuclear, 78460–
8461, 78464–78465, 78472–78473, 78481, 78483;
ositron emission tomography, 78491–78492; stress
chocardiography, 93350). Electrocardiogram stress
nd nuclear imaging procedures performed within 1
ay of each other were considered a stress nuclear
est, whereas ECG stress and echocardiographic
esting performed on the same day were consideredstress echocardiography test. Pharmacological itress was identified using HCPCS codes J0152
adenosine), J1245 (dipyridamole), J1250 (dobut-
mine), and the temporary codes for regadenoson
sed in 2008 (J3490, C9399, C9244); stress tests
ccurring on the same day (or in the case of nuclear
tress testing, within 1 day) as pharmacological
tress codes were considered pharmacological stress
ests.
The number and dates of repeat catheterizations
nd revascularization (either PCI or coronary artery
ypass graft [CABG] surgery) after stress testing
ere identified using International Classification of
iseases, Ninth Revision, Clinical Modification
ICD-9-CM), and HCPCS codes (catheterization,
3508, 93539–93540, 93545; PCI, 92980–92982,
2984, 92995–92996, G0290, G0291, 36.01–36.02,
6.05–36.07, 00.66; CABG, 33510–33514, 33516–
3519, 33521–33523, 33533–33536, 36.1x, 36.2,
2205–S2209).
Statistical analysis. Temporal trends in the utiliza-
ion of stress testing within a year after PCI,
xcluding the 60-day “blackout period,” were as-
essed by calculating the rate of stress testing per
00 person-years and testing, based on calendar
uarter, using Poisson regression. The utilization of
tress testing after PCI was also measured using
umulative incidence functions, treating catheter-
zation, revascularization, readmission for MI, use
f CTA, and death as competing risks, and loss to
ollow-up as censoring. For patients who under-
ent stress testing, quarterly time trends in the use
f testing modalities relative to other modalities
ere assessed using logistic regression models. We
sed 3 binary comparisons of modality: 1) exercise
CG versus exercise imaging (nuclear or echocar-
iography); 2) pharmacological stress testing with
maging versus exercise stress testing with imaging;
nd 3) exercise echocardiography versus exercise
uclear testing. Patient and hospital characteristics
ere provided overall and stratified by test modality
sing descriptive statistics (number of observations,
ean, standard deviation, median, 25th and 75th
ercentiles, minimum, and maximum) for continu-
us variables and with frequency and percentage for
ategorical variables. Bivariate tests of association
ere conducted using chi-square tests for categor-
cal variables and Kruskal-Wallis tests for continu-
us variables. To identify adjusted predictors of
maging modality, we performed logistic regres-
ion for the 3 binary comparisons outlined above.
odels were adjusted for demographic, clinical,
nd procedural characteristics, facility character-
stics, time between PCI and stress test, calendar
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972quarter of testing, and Census Division of patient’s
residence.
Associations between test modality and use of
coronary procedures within the 90 days after the
initial stress test, including additional stress testing,
cardiac catheterization, or repeat revascularization,
was measured using cumulative incidence functions
where loss to follow-up was considered a censoring
event and death a competing risk. For patients who
received a cardiac catheterization after their initial
stress test, the short-term revascularization rate
after catheterization was computed as the cumula-
tive incidence of a repeat revascularization proce-
dure within 90 days of catheterization, treating loss
to follow-up as censoring and death a competing
risk. Tests of association were conducted using
Gray’s test (14).
Analyses were conducted using SAS version 9.2
(SAS Institute, Cary, North Carolina), R version
2.11.1 (R Foundation, Vienna, Austria), and Stata/IC
version 12.0 (StataCorp, College Station, Texas).
The Duke University Medical Center institutional
review board granted a waiver of informed consent
CathPCI Registry Cohort
N = 672,617
Matched to CMS Data
N = 443,922
Overall Study Population
N = 284,971
Stress Testing PopuIation
N = 68,292
Stress Test Between
61-365 Days Post PCI
N = 80,612
Received bot
No continuou
invalid follow
Incomplete c
primary pay
Index PCI ad
Death, FFS d
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Death, FFS d
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Inpatient stre
Stress PET (
Coded as bo
Coded as Str
Figure 1. Population Flow Diagram
Flow diagram showing the process used to deﬁne the study popula
and Medicaid Services; CTA  computed tomography angiography
resonance imaging; PCI  percutaneous coronary intervention; PET  pand authorization for this study, and analyses were
conducted at the Duke Clinical Research Institute.
R E S U L T S
The study population included 284,971 patients
who received PCI between 2005 and 2008, for
whom it was possible to link the procedural and
claims data sets, and survived without repeat cath-
eterization, revascularization, MI, or CTA for 60
days after the initial PCI date (Fig. 1). Median
follow-up time was 584 days (interquartile range:
612 days). Among these 284,971 patients, the
incidence of stress testing that was not preceded by
a repeat catheterization or revascularization, MI, or
CTA was 32.5%.
The test modalities of 68,292 stress test recipi-
ents were evaluated. Among these patients, 5,034
(7.4%) received exercise ECG testing as their first
stress test; 26,679 (39.1%) exercise nuclear testing;
5,286 (7.7%) exercise echocardiography; 30,604 (44.8%)
pharmacological nuclear test; and 689 (1.0%) pharma-
cological echocardiography. Because of the infre-
g Eluting and Bare Metal Stents (N = 18,318)
S Medicare A and B enrollment before PCI,
ength, or missing covariates (N = 26,056)
 physician claim data or Medicare not
ring PCI (N = 34,074)
ion date prior to 1/1/2005 (N = 3,315)
rollment, repeat revascularization, catheterization,
I, or CCTA within 60 days following index PCI (N=61,770)
rollment, repeat revascularization, catheterization,
I, or CCTA prior to 1/1/2006 (N = 15,418)
ed by FFS de-enrollment, repeat revascularization,
dmission for MI, or CCTA (N = 4,846)
st (N = 6,845)
09) or Stress MRI (N = 47)
ess Echo and Stress Nuclear (N = 80)
CG with Pharmacologic Stress (N = 93)
. AMI  acute myocardial infarction; CMS  Centers for Medicare
 electrocardiogram; FFS  fee-for-service; MRI  magnetich Dru
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973quency of pharmacological echocardiography, phar-
macological tests were combined.
Temporal trends in overall stress testing utilization and
in test modalities. The stress test incidence rate after
PCI fell from 59.3 per 100 person-years in the first
quarter of 2006 to 47.1 in the fourth quarter of
2008 (Fig. 2); the unadjusted incidence rate ratio
was 0.984 per quarter (p  0.001). This trend
orresponds to a decline of 17% in incidence from
5.2% in the first quarter of 2006 to 29.4% in the
ourth quarter of 2008. Adjustment did not alter the
ndings (adjusted incidence rate ratio: 0.983, p 
.001).
Among patients receiving exercise testing, the
robability of ECG-only testing compared to exer-
ise stress with imaging increased slightly over time
Fig. 3). This increase was not significant in unad-
usted analyses (odds ratio [OR]: 1.009 per quarter,
 0.052), but became significant after adjustment
OR: 1.020, p  0.001). In contrast, among pa-
ients receiving a stress test with imaging (nuclear
r echocardiography), the probability of pharmaco-
ogical stress in unadjusted analysis (OR: 1.010, p
.001) increased slightly with time. However, this
ifference was diminished after adjustment (OR:
.003, p  0.24). Among patients receiving an
xercise test with imaging, the change in probability
f receiving echocardiography versus nuclear imag-
ng was not statistically significant in unadjusted
nalysis (OR: 0.992, p  0.06), but was in adjusted
nalyses (OR: 0.990, p  0.04).
Predictors of stress test modality. In general, patients
eceiving exercise ECG were clinically similar to
atients receiving an exercise stress test with imag-
ng (Table 1). Exceptions included ECG-only test-
ng recipients being older, more likely to have a
istory of heart failure and diabetes mellitus, and
ess likely to have a history of revascularization
efore the index procedure. They were also more
ikely to have received their index PCI in response
o an MI. Patients who received stress testing
urther from their date of index PCI were substan-
ially less likely to have an exercise ECG test (Fig. 4).
fter adjustment (Table 2), few clinical character-
stics were strongly associated with receipt of exer-
ise ECG versus exercise imaging. Geographic
ariation was present in the use of exercise stress
ith (versus without) imaging—a variation that
ersisted after adjustment (Fig. 5). The adjusted
robability a patient would receive an exercise ECG
est rather than exercise imaging ranged from 6.8%
n the West North Central Census Division to
2.8% in the East South Central Census Division. pMarked differences were evident in characteris-
ics between patients receiving pharmacological
ests versus exercise tests with imaging, with phar-
acological stress testing patients having a higher
urden of cardiovascular risk factors. Pharmacolog-
cal stress test patients were older (52.5% were 75
ears or older vs. 36.0% in the exercise imaging
roup, p 0.001) and were more likely to have had
history of heart failure at the time of their index
CI (13.0% vs. 5.7%, p  0.001). In addition,
harmacological stress recipients reported higher
ates of virtually all other comorbidities. After multivari-
ble adjustment (Table 2), increasing age and most
omorbidities remained strong predictors of phar-
acological testing with imaging rather than exer-
ise testing with imaging. Minimal geographic
ariation was observed in the use of exercise stress as
ompared to pharmacological stress when perform-
ng an imaging stress test—even after statistical
djustment (Fig. 5). The notable exception was
ew England, where relatively few pharmacological
ests were performed.
Patients receiving exercise echocardiography had
lower burden of cardiovascular risk factors com-
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974with echocardiography patients having lower rates
of most comorbidities. Patients receiving echocar-
diography were also less likely to have had diag-
nosed multivessel disease at the time of PCI (46.5%
vs. 51.1%, p  0.001); however, after adjustment
(Table 2), few clinical characteristics were strongly
associated with receipt of echocardiography versus
nuclear testing. Geographic variation existed in the
use of exercise echocardiography compared with
exercise nuclear testing, with rates varying from
9.4% in the South Atlantic Census Division to
34.1% in the Pacific Division.
Downstream procedures after stress testing. The in-
cidence of repeat stress testing within 90 days of the
initial stress test varied markedly depending on the
type of first test, from 2.1% (pharmacological im-
aging) to 13.7% (exercise ECG) (Table 3). The
incidence of repeat stress testing was higher after
nonimaging tests compared to imaging exercise
tests, exercise echocardiography compared with ex-
ercise nuclear imaging tests, and exercise imaging
versus pharmacological stress imaging (all p 
0.001). The incidence of catheterization within 90
days after stress testing also varied substantially,
being lowest for exercise ECG (7.4%) and highest
for the pharmacological tests (15.8%). The inci-
dence was lower in nonimaging tests compared to
imaging exercise tests, exercise tests versus pharma-
cological tests, and exercise echocardiography com-
pared to exercise nuclear imaging (p  0.001 for
all). The incidence of repeat revascularization after
stress testing was somewhat less variable, ranging
from 3.8% (exercise ECG) to 7.6% (pharmacolog-
ical testing). The incidence was lower after nonim-
aging tests compared with exercise imaging tests,
and exercise echocardiography compared with ex-
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Figure 3. Temporal Trends in Stress Testing Modality
Trends in percentage of stress tests performed with (A) exercise ele
(Pharm.) stress with imaging versus exercise stress with imaging, an
based on calendar quarter in which stress test was performed. Odd
patient, procedural, facility, and geographic characteristics using logercise nuclear testing (p  0.001 and p  0.02,espectively); rates were similar for exercise and
harmacological imaging tests (p  0.13). Despite
arying use of additional diagnostic procedures, the
evascularization rate after catheterization (the in-
idence of a repeat revascularization within 90 days
f a post-stress test catheterization) varied little
cross imaging modality. The only statistically sig-
ificant difference noted was a slightly lower rate
mong pharmacological imaging tests compared
ith exercise imaging (47.8% vs. 51.0%, p 
.002).
D I S C U S S I O N
Creation of a data set linking detailed clinical
information from the CathPCI Registry with inpa-
tient and ambulatory Medicare claims enabled an
evaluation of processes of care related to stress
testing among a broad cohort of patients ages 65
years and older. We found that between 2006 and
2008, stress testing utilization declined roughly
equally across testing modalities. Geographic region
was strongly associated with the modality patients
received and notable differences occurred in the
downstream procedure use associated with each
modality.
Consistent with previous reports on stress test
use among Medicare beneficiaries, the overall rate
of stress testing after PCI declined modestly over
time (8). With the exception of a slight increase
in the proportion of tests performed without imag-
ing, the decline was uniform across imaging mo-
dalities. The explanation for these trends is unclear,
but they temporally coincide with reductions in test
reimbursement associated with the Deficit Reduc-
tion Act of 2005, the introduction of ACCF AUC
 of Stress Test
7 2008
= 31,293) vs.
 = 31,965)
: 1.010 (1.005, 1.015)
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Calendar Quarter of Stress Test
C
2006 2007 2008
Exercise Echocardiography (N = 5,286) vs.
Exercise Nuclear (N = 26,679)
Unadjusted OR (CI): 0.992 (0.983, 1.000)
Adjusted OR (CI): 0.990 (0.981, 1.000)
0
5
10
15
20
cardiography (ECG) versus exercise imaging, (B) pharmacological
) exercise echocardiography versus exercise nuclear testing,
tios (OR) were calculated, both unadjusted and adjusted, for
regression. CI  conﬁdence interval.arter
200
g (N 
ing (N
 (CI)
CI): 1
ctro
d (C
s rafor imaging, and an increasing concern regarding
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 5 , N O . 1 0 , 2 0 1 2
O C T O B E R 2 0 1 2 : 9 6 9 – 8 0
Federspiel et al.
Stress Testing Patterns After PCI
975Table 1. Baseline and Descriptive Characteristics of Patients Receiving Stress Testing Between 61 and 365 Days Post-Percutaneous Coronary Revascularization
Total
(N  68,292)
(1)
Exercise
ECG
(n  5,034)
(2)
Exercise
Nuclear or
Echo
(n  31,965)
p
Value
1 vs. 2
(3)
Exercise
Nuclear
(n  26,679)
(4)
Exercise
Echo
(n  5,286)
p
Value
3 vs. 4
(5)
Pharm
Imaging*
(n  31,293)
p
Value
2 vs. 5
Demographic and clinical characteristics
at time of index PCI
Age, yrs, median (Q1–Q3) 73 (68–78) 73 (68–78) 72 (68–77) 0.001 72 (68–77) 72 (68–77) 0.98 75 (70–80) 0.001
75 years or older 43.8 40.0 36.0 0.001 36.0 35.8 0.79 52.5 0.001
Female 41.1 34.6 34.1 0.46 34.0 34.7 0.29 49.4 0.001
White race 88.9 88.0 89.5 0.002 89.6 89.2 0.40 88.5 0.001
BMI, median (Q1–Q3), kg/m2 28 (25–31) 28 (25–31) 27 (25–31) 0.08 27 (25–31) 27 (25–30) 0.007 28 (25–32) 0.001
Previous MI (7 days) 21.6 18.9 19.7 0.17 20.0 18.2 0.002 24.0 0.001
History of heart failure 9.1 6.7 5.7 0.004 5.8 4.8 0.002 13.0 0.001
Family history of CAD 20.4 20.1 20.9 0.18 21.2 19.2 0.001 20.0 0.003
Hypertension 80.4 77.3 77.0 0.64 77.5 74.9 0.001 84.4 0.001
Diabetes mellitus 29.8 27.4 24.7 0.001 24.9 23.5 0.03 35.5 0.001
GFR 30 ml/min/1.73m2 or dialysis
dependent
2.7 1.7 1.6 0.03 1.6 1.4 0.30 4.0 0.001
PVD 12.4 9.0 9.1 0.79 9.2 8.3 0.03 16.4 0.001
Statin use 75.7 75.1 75.5 0.61 75.9 73.3 0.001 76.1 0.06
Current smoker 10.9 9.6 10.5 0.06 10.4 10.4 0.67 11.4 0.001
Previous revascularization 38.2 32.1 35.6 0.001 36.0 33.6 0.001 41.8 0.001
Cardiac status at time of PCI
presentation
0.001 0.007 0.001
Asymptomatic 15.0 12.0 14.5 14.8 13.5 16.0
Atypical chest pain 8.1 7.5 8.0 8.2 7.1 8.3
Stable angina 18.3 16.9 18.7 18.5 19.5 18.1
Unstable angina 33.5 30.9 33.1 33.1 33.4 34.3
NSTEMI 14.4 17.2 13.8 13.7 14.1 14.6
STEMI 10.7 15.6 11.8 11.7 12.4 8.7
Multivessel disease 52.6 52.0 50.4 0.03 51.1 46.5 0.001 55.0 0.001
PCI procedure and facility characteristics
PCI status 0.001 0.001 0.001
Elective 53.4 47.3 53.1 53.7 50.4 54.7
Urgent 34.7 36.2 34.1 36.1 36.1 35.0
Emergency 11.8 16.5 12.7 12.5 13.5 10.2
Salvage 0.1 0.1 0.1 0.1 0.1 0.1
Drug-eluting stent used 75.7 75.6 77.4 0.004 77.5 76.9 0.36 73.9 0.001
Census Division 0.001 0.001 0.001
New England 5.1 10.9 5.9 6.2 4.8 3.3
Middle Atlantic 7.0 4.8 7.2 7.6 5.1 7.0
East North Central 23.4 22.0 22.4 22.8 20.5 24.6
West North Central 9.8 4.5 10.0 9.7 11.3 10.4
South Atlantic 24.0 20.6 24.7 27.0 13.2 23.9
East South Central 7.0 11.8 6.7 7.0 5.1 6.7
West South Central 7.8 6.9 7.0 6.8 7.8 8.8
Mountain 5.7 7.1 5.6 4.6 10.4 5.5
Paciﬁc 10.3 11.3 10.6 8.4 21.9 9.8
Testing characteristics
Time from index PCI to stress test,
median days (Q1–Q3)
186 (119–260) 122 (89–178) 186 (119–258) 0.001 188 (122–261) 174 (109–245) 0.001 196 (128–271) 0.001
Values are median (Q1–Q3) or %. *Pharmacological (Pharm) nuclear and echocardiography (Echo) tests were combined because of small sample size in pharmacological echocardiography arm
(n  711).
BMI body mass index; CABG coronary artery bypass graft; CAD coronary artery disease; CMS Centers for Medicare and Medicaid Services; ECG electrocardiography; GFR glomerular
ﬁltration rate; MImyocardial infarction; NSTEMI non–ST-segment elevation myocardial infarction; PCI percutaneous coronary intervention; PVD peripheral vascular disease; Q quartile;
STEMI  ST-segment elevation myocardial infarction.
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976possible overuse. If related, perhaps greater atten-
tion to testing utilization spearheaded by the new
standards or a diminishing financial return may be
an underlying cause. Because all included patients
were enrolled in FFS Medicare at the time of
testing, none were subject to radiology benefit
management. While it is possible that benefit man-
agement in privately insured patients may have a
spillover effect in the FFS population, the direction
of the effect cannot be predicted with certainty. Use
would decline if providers perceive the burdens of
testing not to be worth the effort or if providers are
educated by encounters with radiology benefit man-
agement regarding appropriate use (15), but use
would increase among FFS patients if pressure to
maintain testing volume causes providers to in-
crease testing in marginally appropriate patients.
There were few strong clinical or demographic
predictors of receipt of exercise ECG versus exercise
imaging stress testing. This result may be in part
due to the absence of detailed electrocardiographic
data indicating contraindications to ECG-only
testing, such as left bundle branch block, electronic
pacing, or left ventricular hypertrophy with repo-
larization abnormalities (16). Similarly, there were
few strong clinical or demographic predictors of
receipt of exercise echocardiography versus exercise
Exercise Stress with Imaging
Pharmacologic Stress with Imaging
Exercise Stress with Electrocardiogram Only
Months Since Index PCI
2 4 6 8 10 12
Relationship Between Imaging Modality and Time Since PCI
the percentage of stress tests performed with exercise electrocar-
(red line), exercise imaging (green line), or pharmacological
ellow line), based on number of months between patient’s index
us coronary intervention (PCI) procedure and stress test.nuclear imaging. Particularly surprising was theabsence of a relationship for body mass index (OR:
0.99 per unit, p  0.64), despite evidence that
nuclear imaging may be (with appropriate attenua-
tion adjustment) more feasible than echocardiogra-
phy for patients with higher body mass index
(17,18). In contrast, age (OR: 2.12 per decade) and
comorbidities were strong predictors of pharmaco-
logical stress testing versus exercise testing with
imaging. Although the data do not provide direct
measures of exercise tolerance or frailty, age and
comorbidities are indirect measures of these phe-
nomena. In aggregate, these results suggest provid-
ers actively weigh these considerations when select-
ing pharmacological agents as the stress protocol.
In contrast to patient characteristics, geographic
variation was strongly associated with the addition
of imaging to exercise, and in the type of imaging
used among patients receiving an imaging-based
exercise test. These large-area patterns are consis-
tent with previous, small-area studies demonstrat-
ing large, idiosyncratic variation in stress testing
rates and the use of imaging with stress testing (19).
The reasons for large-scale variation in imaging use
and modality are unclear, but may be due to
diffusion of practice preferences from regional
“thought leaders,” differences in population-level
preferences for high technology care, or spillover
effects from differences in the private insurance
marketplace. Less geographic variability occurred in
pharmacological versus exercise imaging. Although
our data cannot directly address adherence to na-
tional guidelines recommending the use of pharma-
cological stress only among those patients unable to
exercise, it does suggest that physician judgment
about which patients are able to exercise is relatively
uniform nationwide.
In general, subsequent procedures were uncom-
mon, suggesting that stress tests are employed in
the post-PCI population for low-risk indica-
tions—a result consistent with findings using a
private insurer’s database (9). Compared with those
receiving exercise imaging, patients receiving
ECG-only testing experienced higher rates of ad-
ditional stress testing, with more than 1 in 7
patients receiving a subsequent stress test within 90
days—most of which (73.2%) were performed with
imaging. In contrast, exercise ECG patients had
lower rates of catheterization compared with pa-
tients tested initially with imaging. While our find-
ings are limited by their observational nature, they
suggest that a strategy of using exercise ECG first,
reserving imaging for use after an equivocal study or inTe
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977Table 2. Selected Adjusted Predictors of Stress Testing Modality
Exercise ECG (n  5,034)
vs. Exercise Imaging
(n  31,965)
Pharm Imaging
(n  31,293) vs. Exercise
Imaging (n  31,965)
Exercise Echo (n  5,286)
vs. Exercise Nuclear
(n  26,679)
OR (95% CI) p Value OR (95% CI) p Value OR (95% CI) p Value
Demographic and clinical characteristics at time of index PCI
Age, per 10 yrs 1.20 (1.14–1.27) 0.001 2.12 (2.06–2.19) 0.001 0.99 (0.93–1.05) 0.64
BMI, per unit, kg/m2 1.01 (1.01–1.02) 0.001 1.05 (1.05–1.06) 0.001 1.00 (0.99–1.00) 0.30
White race vs. other 0.88 (0.80–0.98) 0.01 0.92 (0.88–0.98) 0.005 1.12 (1.01–1.23) 0.03
Male vs. female 1.04 (0.97–1.12) 0.23 0.56 (0.54–0.58) 0.001 0.95 (0.89–1.02) 0.15
PVD 0.99 (0.89–1.11) 0.89 1.52 (1.44–1.60) 0.001 0.97 (0.87–1.08) 0.58
History of heart failure 1.16 (1.01–1.33) 0.03 1.58 (1.48–1.69) 0.001 0.83 (0.72–0.97) 0.02
Diabetes mellitus 1.15 (1.07–1.24) 0.001 1.44 (1.39–1.50) 0.001 0.99 (0.92–1.07) 0.87
Hypertension 0.97 (0.90–1.05) 0.39 1.20 (1.15–1.26) 0.001 0.93 (0.86–1.00) 0.06
Statin use 1.04 (0.96–1.12) 0.36 0.90 (0.87–0.94) 0.001 0.93 (0.87–1.00) 0.06
Current smoker 0.94 (0.84–1.05) 0.26 1.50 (1.42–1.59) 0.001 1.03 (0.93–1.14) 0.57
Family history of CAD before age 55 0.96 (0.86–1.06) 0.40 1.29 (1.23–1.36) 0.001 1.08 (0.98–1.20) 0.13
Previous MI (7 days from PCI) 1.01 (0.94–1.10) 0.74 0.95 (0.91–0.99) 0.009 0.95 (0.88–1.03) 0.19
GFR 30 ml/min/1.73m2 or dialysis dependent, vs. GFR 60 1.04 (0.97–1.12) 0.23 1.19 (1.15–1.23) 0.001 1.04 (0.97–1.11) 0.28
Previous PCI 0.87 (0.80–0.95) 0.001 1.14 (1.09–1.19) 0.001 1.01 (0.94–1.09) 0.78
Previous CABG 1.04 (0.95–1.14) 0.42 1.23 (1.17–1.29) 0.001 0.98 (0.89–1.08) 0.68
Cardiac status at time of PCI admission presentation, vs. stable
angina
No symptoms 0.98 (0.87–1.10) 0.69 1.10 (1.04–1.16) 0.002 0.94 (0.85–1.05) 0.27
Atypical chest pain 1.05 (0.91–1.20) 0.52 1.06 (0.99–1.14) 0.10 0.82 (0.72–0.93) 0.003
Unstable angina 0.99 (0.89–1.08) 0.75 1.02 (0.97–1.07) 0.56 1.00 (0.91–1.10) 0.98
NSTEMI 1.21 (1.07–1.36) 0.002 1.04 (0.97–1.11) 0.26 0.92 (0.82–1.03) 0.16
STEMI 1.25 (1.07–1.47) 0.006 0.85 (0.77–0.93) 0.001 0.88 (0.75–1.03) 0.12
Multivessel disease 1.01 (0.94–1.07) 0.89 1.11 (1.07–1.15) 0.001 0.86 (0.80–0.91) 0.001
PCI procedure and facility characteristics
PCI status vs. elective
Urgent 0.95 (0.38–2.34) 0.91 0.99 (0.95–1.03) 0.49 1.14 (1.06–1.23) 0.001
Emergency 1.05 (0.91–1.21) 0.49 1.07 (0.99–1.17) 0.10 1.12 (0.97–1.29) 0.13
Salvage 0.95 (0.38–2.34) 0.91 1.36 (0.82–2.28) 0.24 0.85 (0.32–2.29) 0.75
Drug-eluting vs. bare metal stents 1.11 (1.03–1.20) 0.007 0.86 (0.83–0.90) 0.001 0.93 (0.87–1.01) 0.08
Census division vs. South Atlantic
New England 1.99 (1.75–2.27) 0.001 0.60 (0.55–0.66) 0.001 1.13 (0.96–1.33) 0.14
Middle Atlantic 0.76 (0.65–0.89) 0.001 1.08 (1.00–1.16) 0.05 1.20 (1.02–1.40) 0.02
East North Central 1.30 (1.18–1.43) 0.001 1.10 (1.04–1.16) 0.001 1.76 (1.58–1.96) 0.001
West North Central 0.56 (0.48–0.66) 0.001 1.12 (1.05–1.19) 0.001 2.18 (1.92–2.47) 0.001
East South Central 2.43 (2.16–2.73) 0.001 1.05 (0.98–1.13) 0.19 1.51 (1.29–1.76) 0.001
West South Central 1.30 (1.13–1.49) 0.001 1.38 (1.28–1.48) 0.001 2.14 (1.86–2.45) 0.001
Mountain 1.73 (1.50–1.99) 0.001 1.14 (1.05–1.24) 0.002 4.26 (3.71–4.88) 0.001
Paciﬁc 1.30 (1.15–1.47) 0.001 1.00 (0.93–1.07) 0.92 5.08 (4.53–5.70) 0.001
PCI hospital vs. university
Government 0.63 (0.46–0.85) 0.002 1.32 (1.15–1.52) 0.001 0.20 (0.14–0.28) 0.001
Private and nonteaching 1.04 (0.92–1.18) 0.49 1.28 (1.19–1.38) 0.001 0.54 (0.48–0.60) 0.001
Private and teaching 0.89 (0.80–1.00) 0.06 1.13 (1.06–1.22) 0.001 0.56 (0.50–0.63) 0.001
Average annual PCI volume, per 100 increase 0.99 (0.99–1.00) 0.001 1.00 (0.99–1.00) 0.001 0.99 (0.98–0.99) 0.001
No. of CMS-certiﬁed beds, per 100 increase 1.08 (1.06–1.09) 0.001 1.01 (1.01–1.02) 0.001 1.01 (1.00–1.03) 0.12
Calendar quarter of stress test 1.02 (1.01–1.03) 0.001 1.00 (1.00–1.01) 0.24 0.99 (0.98–1.00) 0.04
Time from PCI to stress test, per 30 days 0.80 (0.79–0.81) 0.001 1.04 (1.03–1.04) 0.001 0.96 (0.95–0.97) 0.001CI  conﬁdence interval; OR  odds ratio; other abbreviations as in Table 1.
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978ing, may be reasonable. This strategy was supported
by a recent trial comparing ECG-only versus nuclear
stress testing for initial diagnosis of coronary artery
disease among women, which showed that despite
greater need for additional testing, the “exercise ECG
first” strategy was cost saving (20).
Compared with nuclear testing, exercise echocar-
diography resulted in more subsequent stress test-
ing, potentially due to the more challenging inter-
pretation of echocardiography studies or less physician
confidence in results (21). The rate of catheterization
was also slightly lower, suggesting that downstream
processes of care may differ as a result. Patients
receiving pharmacological stress testing experienced a
lower rate of additional stress testing and had a similar
rate of proceeding to catheterization, but had a slightly
lower revascularization rate after catheterization. It is
unclear whether the lower revascularization rate after
catheterization among pharmacological stress patients
is the result of lower stress test specificity due to the
absence of exercise tolerance data, or if physicians are
A B
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of any revascularization within 90 days of the date of catheterization, among pa
1.more reluctant to revascularize pharmacological stress
recipients, who are on average older and with a higher
burden of comorbidities.
Certain factors should be considered in the in-
terpretation of these results. The use of combined
CathPCI Registry and Medicare data allowed for
analysis of a large, well-described population of
patients. Nevertheless, data are limited to FFS
Medicare patients ages 65 years and older, and
findings may not generalize outside this population.
Findings may also not generalize to patients treated
at facilities not participating in the CathPCI Reg-
istry, or to patients whose CathPCI Registry record
could not be merged with Medicare claims data;
however, recent work suggests that the linked
dataset is generalizable in this respect (13). The
CathPCI Registry data provide a clinical descrip-
tion of the time of PCI, but data on symptoms,
ECG parameters, and ability to exercise at the time
of testing are unavailable, limiting our ability to
fully adjust regression models and preventing iden-
C
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979tification of the concordance of testing patterns
with current AUC.
C O N C L U S I O N S
This analysis uses a post-PCI population to evalu-
ate processes of care related to stress testing and
provides several important implications for practice
and future investigations. Declining test utilization
in the post-PCI population suggests that multi-
pronged efforts are having a measurable effect.
Additional research is needed to ensure that unin-
tended consequences do not result, such as limiting
access for patients with legitimate testing needs.
Patients receiving imaging stress had more down-
stream procedures than patients receiving ECG-
only testing. Taken together with the large geo-
graphic variations in use of stress testing modalities,
these findings suggest there would be value in
determining more precisely the optimal use of stress
test modalities after PCI in individual patients.2009 appropriate use criteria for car-
1
1
1
1
hort of elderly paprospectively collected data so that clinical status
and indications for testing are captured. Finally,
associations between modality and downstream
procedures observed in this analysis also indicate
that attempts to define the costs and benefits of
stress test modalities should consider their effects
not only on testing cost, but on the entire episode of
care. As efforts continue to identify the optimal use
of stress testing after PCI while controlling cost,
carefully constructed, holistic evaluations will pro-
vide important guidance.
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